- Home
- IBRX vs PLNT Comparison
IBRX vs PLNT Comparison
Compare IBRX & PLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IBRX | PLNT |
|---|---|---|
| Founded | 2014 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | 6.3B |
| IPO Year | 2015 | 2015 |
Fundamental Metrics
Financial Performance| Metric | IBRX | PLNT |
|---|---|---|
| Price | $7.41 | $69.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 12 |
| Target Price | $12.57 | ★ $115.17 |
| AVG Volume (30 Days) | ★ 14.7M | 1.1M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $113,288,000.00 | ★ $1,324,144,000.00 |
| Revenue This Year | $88.59 | $19.22 |
| Revenue Next Year | $131.15 | $11.66 |
| P/E Ratio | ★ N/A | $38.47 |
| Revenue Growth | ★ 668.31 | 12.06 |
| 52 Week Low | $1.83 | $67.82 |
| 52 Week High | $12.43 | $114.47 |
Technical Indicators
Market Signals| Indicator | IBRX | PLNT |
|---|---|---|
| Relative Strength Index (RSI) | 46.98 | 36.13 |
| Support Level | $2.22 | $69.10 |
| Resistance Level | $8.28 | $76.74 |
| Average True Range (ATR) | 0.56 | 2.00 |
| MACD | 0.06 | 0.14 |
| Stochastic Oscillator | 39.03 | 22.18 |
Price Performance
Historical ComparisonAbout IBRX ImmunityBio Inc.
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
About PLNT Planet Fitness Inc.
Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.